By Chris Wack
Bluejay Diagnostics shares were down 50% to 82 cents, a 52-week low, after an underwritten public offering priced with proceeds expected to be about $8.75 million.
The stock closed Wednesday's session down 41%, and is now down 97% in the past 12 months.
The medical technology company said the base offering consists of 5.37 million units or prefunded units.
Each unit consists of one share of Bluejay stock or one pre-funded warrant, two class C warrants and one class D warrant. The purchase price of each unit was $1.63.
The closing of the offering is expected to occur Friday.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
June 27, 2024 10:08 ET (14:08 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments